Pieris Pharmaceuticals Inc Stock, NASDAQ:PIRS
255 State Street, 9th floor, Boston, Massachusetts 02109
United States of America
Number of Employees: 123
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.